Delivery Order SPE2DB22D2009-SPE2DB25FM1BQ
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $7,769.62 to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of 36,000 unit capsules of Creon in 100-count packaging. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award to this pharmaceutical distributor based on merit. Performance will be completed by August 18, 2025, at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $42,783.63 to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of 36,000 units of Creon DR 100s capsules. The contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award, and is scheduled for completion by August 20, 2025. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of 36,000 units of Creon DR 100s capsules, valued at $6,150.38. This competitively awarded, firm fixed-price delivery order is set to be completed by July 30, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal...
- The Defense Logistics Agency awarded a delivery order valued at $3,088.91 to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100 mg capsules. This non-competitive, firm fixed price delivery order was awarded on July 30, 2025, with an ultimate completion date of July 31, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. As a child contract under a larger vehicle, this delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of 36,000 units of Creon DR 100s capsules, with a ceiling value of $11,594.70. This competitive award, issued with firm fixed-price pricing and no set-aside designation, is fulfilled from the company's place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. This delivery order is a child contract under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Creon DR 36,000 unit capsules in quantities of 100 units. This non-set-aside, firm fixed-price delivery order has a ceiling value of $6,733.40 and is scheduled for ultimate completion by August 19, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $4,656.29 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon DR 100s, a pancreatic enzyme replacement therapy. This firm fixed price delivery order was competitively awarded without set-aside designation and is scheduled for completion by July 29, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- Amerisourcebergen Drug Corporation has been awarded a $390 firm fixed price delivery order against an unidentified contracting vehicle to supply 12,000 units of Creon DR capsules to the Defense Logistics Agency by October 20, 2023. The delivery location is Conshohocken, Pennsylvania. No set-aside provisions were applied to this award to supply pancreatic enzyme replacement therapy medications in support of the Defense Logistics Agency's medical logistics responsibilities. Amerisourcebergen...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 24,000 units of Creon DR 100s capsules valued at $7,245.28. The contract utilizes firm fixed price pricing with no set-aside designation, indicating competitive award through open competition. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 30, 2025. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Creon DR 36,000 Unit Capsules in packages of 100 units. This competitive, non-set-aside contract is valued at $1,290.59 with firm fixed pricing and a completion date of August 8, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in Conshohocken, PA...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB25FM1BQDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100s capsules, valued at $5,684.41. This firm fixed-price delivery order, issued on August 22, 2025, represents a non-competitive, non-set-aside award with an ultimate completion date of August 25, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters. This delivery order is executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor agreement that runs through December 2026 and serves as the primary vehicle for global pharmaceutical supply to military healthcare programs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal medical procurement vendor. The company maintains an extensive portfolio of federal contracts with DLA and related Defense Health Agency customers, supplying brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The Creon DR delivery represents one of numerous competitively awarded transactions under the company's comprehensive pharmaceutical support vehicle, demonstrating its continued capability to fulfill federal medical supply requirements for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 8/22/25 |